TY - JOUR
T1 - Generation of natural killer cells from serum-free, expanded human umbilical cord blood CD34+ cells
AU - Kao, I. Ting
AU - Yao, Chao Ling
AU - Kong, Zwe Ling
AU - Wu, Mei Ling
AU - Chuang, Tzu Lin
AU - Hwang, Shiaw Min
PY - 2007/12/1
Y1 - 2007/12/1
N2 - Natural killer (NK) cells are important effectors of the innate immune system, which exhibits cytolytic activity against infectious agents and tumor cells. NK cells are derived from CD34+ hematopoietic stem cells (HSCs). Human umbilical cord blood (UCB) has been recognized as a rich source of HSCs. Previously, we have reported an optimized serum-free medium for ex vivo expansion of CD34+ cells from UCB. In this study, the serum-free, expanded CD34+ cells were tested to differentiate into NK cells and their induction kinetics. After 5 weeks of induction, the induced NK cells were characterized by analysis of surface antigens, IFN-γ secretion, and cytotoxicity against K562 cells. The results indicated that NK cells derived from the serum-free, expanded CD34+ cells exhibited both characteristics and functions of NK cells. Furthermore, the serum-free, expanded CD34+ cells showed a significantly higher NK cell differentiation potential than freshly isolated CD34+ cells. NK cells induced from serum-free, expanded CD34+ cells showed a higher concentration of IFN-γ secretion and ability of cytotoxicity than those from freshly isolated CD34+ cells. Therefore, ex vivo-expanded CD34+ cells in optimized serum-free medium could differentiate into NK cells and provided a promising cell source for immunotherapeutic approaches.
AB - Natural killer (NK) cells are important effectors of the innate immune system, which exhibits cytolytic activity against infectious agents and tumor cells. NK cells are derived from CD34+ hematopoietic stem cells (HSCs). Human umbilical cord blood (UCB) has been recognized as a rich source of HSCs. Previously, we have reported an optimized serum-free medium for ex vivo expansion of CD34+ cells from UCB. In this study, the serum-free, expanded CD34+ cells were tested to differentiate into NK cells and their induction kinetics. After 5 weeks of induction, the induced NK cells were characterized by analysis of surface antigens, IFN-γ secretion, and cytotoxicity against K562 cells. The results indicated that NK cells derived from the serum-free, expanded CD34+ cells exhibited both characteristics and functions of NK cells. Furthermore, the serum-free, expanded CD34+ cells showed a significantly higher NK cell differentiation potential than freshly isolated CD34+ cells. NK cells induced from serum-free, expanded CD34+ cells showed a higher concentration of IFN-γ secretion and ability of cytotoxicity than those from freshly isolated CD34+ cells. Therefore, ex vivo-expanded CD34+ cells in optimized serum-free medium could differentiate into NK cells and provided a promising cell source for immunotherapeutic approaches.
UR - http://www.scopus.com/inward/record.url?scp=37549024529&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=37549024529&partnerID=8YFLogxK
U2 - 10.1089/scd.2007.0033
DO - 10.1089/scd.2007.0033
M3 - Article
C2 - 17999637
AN - SCOPUS:37549024529
SN - 1547-3287
VL - 16
SP - 1043
EP - 1051
JO - Stem Cells and Development
JF - Stem Cells and Development
IS - 6
ER -